Sparano JA, Crager MR, Tang G, Gray RJ, et al. Development and Validation of a Tool Integrating the 21-Gene Recurrence Score and Clinical-Pathological Features to Individualize Prognosis and Prediction of Chemotherapy Benefit in Early Breast Cancer. J Clin Oncol 2020 Dec 11:JCO2003007. doi: 10.1200/JCO.20.03007.
PMID: 33306425